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Abstract
Purpose To investigate whether age influences colonic polyphenol metabolism.
Methods Healthy participants, younger (n = 8; 23–43 years) and older (n = 13; 51–76 years), followed a 3-day low-polyphenol 
diet (LPD) and a 3-day high-polyphenol diet (HPD). Urinary phenolic acids (PA), short chain fatty acids (SCFA), pH and gas 
were monitored, alongside selected colonic bacteria. Human faecal in vitro fermentations of rutin with or without raftiline 
were used to evaluate the gut microbiota capacity in a subset of both groups.
Results Total urinary PA were higher in the older group after HPD compared to the younger group (1.5-fold; p = 0.04), 
with no difference between groups in terms of a change between diets (Δ high-low diet). While 17 PA were detected in all 
younger participants after HPD, a narrower range (n = 8 to 16 PA) was detected in most (n = 9/13) older participants, with 
lower level of benzoic acid (19-fold; p = 0.03), vanillic acid (4.5-fold; p = 0.04) but higher hippuric acid (2.7-fold; p = 0.03). 
Faecal SCFA concentration did not change after HPD within group, with similar differential excretion (Δ high-low diet) 
between groups. There were no differences between groups for faecal pH, total, faecal bacteria including Flavonifractor 
plautii, bifidobacteria, and bacteroides. In human in vitro faecal fermentations, seven PAs were detected in both groups after 
24 h of rutin fermentation, with no quantitative and modest qualitative differences between groups. Total SCFA in faecal 
fermentation did not differ between groups, except for butyric acid (twofold higher in the older group; p = 0.009) when rutin 
was fermented with raftiline over 24 h.
Conclusions Urinary phenolic acids were less diverse in older participants despite limited difference in functional capacity 
of in vitro faecal fermentations.
Keywords Ageing · Colon · Metabolism · Microbiota · Polyphenols · Inter-individual variability · Gut · Fermentation · 
Phenolic acid · Age
Introduction
The number of adults aged 60 years and over will double 
between 2000 and 2050, from 11 to 22% [1] globally. The 
increase in lifespan has a direct effect on the incidence of 
age-related diseases, including colorectal cancer (CRC), 
which can put a tremendous strain on health services [2].
The importance of the role of the gut microbiota in health 
has been increasingly demonstrated. The composition of the 
colonic microbiota is altered in the elderly with potentially 
beneficial species, such as Bifidobacteria, Bacteroides, and 
Lactobacilli declining, and potentially harmful bacteria, 
such as Escherichia coli, Enterobacteriaceae and Clostrid-
ium perfringens, increasing [3].
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Changes in the colonic microbiota and its metabolic 
products including short chain fatty acids (SCFA), butyrate, 
acetate and propionate, could directly affect the proliferation, 
differentiation, and gene expression of the colonic epithe-
lium [4–6]. Butyrate is the primary energy source for colo-
nocytes, and may play a key role in maintaining homeostasis 
of the colonic mucosa inhibiting proliferation and inducing 
apoptosis and differentiation in colorectal cancer cell lines 
[7, 8].
Plant foods contain a large range of bioactive molecules, 
including (poly)phenolics. The conversion of the parent 
(poly)phenolic compound (poorly bioavailable) to smaller 
phenolic acids (with increased bioavailability) by the colonic 
microbiota is likely to be an important contributor to the 
beneficial effect ascribed to the compounds.
There is an emerging body of work on the potential 
impact of (poly)phenolic metabolites on age-related factors 
(inflammation, oxidative stress, glycation, dysbiosis) con-
tributing to chronic diseases such as CRC [9–14]. Recently, 
the International Scientific Association for Probiotics 
and Prebiotic expanded the definition of the prebiotics to 
include (poly)phenolics as they are selectively metabolised 
by gut microbiota and release microbial bioactive molecules 
(including phenolic acids) that may confer local and system-
atic health benefits [15]. The interactions between the gut 
microbiota and (poly)phenols have been described in two 
ways: (1) some (poly)phenols metabolites have the capa-
bility to promote and/or inhibit the growth certain bacteria 
[16] and (2) the gut microbiota contributes to the production 
of small potentially bioactive molecules including phenolic 
acids [17]. (Poly)phenolics may have protective effects in the 
gastrointestinal tract by: (1) inhibiting the growth of patho-
genic species, e.g. Clostridium spp, Staphylococcus aureus, 
and Bacteroides spp. [18]; (2) suppressing the adhesion of 
gut pathogens to human gut cells [19]; (3) enhancing natu-
ral killer cell activity and cytokine secretion [20]. In older 
adults (40–50 years old), a higher urinary concentration of 
phenolic metabolites of anthocyanin such as syringic acid, 
p-coumaric acid, 4-hydroxybenzoic acid, and homovanillic 
acid was associated with higher bifidobacteria level (> 4.47 
vs. < 1.18  log10copies per g faeces) [17].
Research into the bioavailability and metabolism of 
(poly)phenols, has so far been mostly limited to young 
adults [21–26], and inter-individual factors likely to impact 
on the outcome measures have rarely been studied in depth 
[27–33]. One study, in particular, looked at the effect of age-
ing on the absorption, metabolism, and excretion of epicat-
echin in healthy younger and older subjects after the con-
sumption of cocoa flavanols, with little difference observed 
between subjects; the study did not, however, consider the 
colonic metabolism of epicatechin, or phenolic acids pro-
duction [34]. As a result, very little is currently known 
about the impact of ageing on the metabolic fate of (poly)
phenolics in the human gastrointestinal tract, despite the fact 
that age is a key risk factor for a non-communicable disease 
development.
As the body ages, several changes may influence the bio-
availability and colonic bacterial metabolism of plant (poly)
phenolics: (1) longer transit times [35]; (2) increase in con-
ditions such as irritable bowel syndrome, diverticulosis, and 
colon cancers which are linked with changes in gut micro-
biota [36–39]; (3) reduced chewing strength, leading to dif-
ferent food choices and lower fibre intake [40]; (4) reduced 
physical activity which may affect gut function including 
frequency of bowel movements [41], (5) changes in the com-
position/diversity of the microbiota [3]. As the majority of 
(poly)phenolics are metabolised by bacterial enzymes in the 
colon, this may influence their colonic metabolism.
As there are very limited data on the effect of ageing on 
the bacterial metabolism of (poly)phenols, this study aimed 
to test whether age (≥ 50 years) affects the colonic metabo-
lism of dietary (poly)phenolics, with a focus on flavonols, 
which are ubiquitous in the Western diet. Rutin was used 
as a “model” flavonol as it is a well-characterised molecule 
with published evidence related to its breakdown. Rutin is 
a quercetin glycoside, which resists hydrolysis and is not 
deglycosylated within the human small intestine by cyto-
solic β-glucosidase and/or the lactase–phlorizin hydrolase 
enzymes, and thus pass intact to the large intestine. Rutin is 
degraded in the colon by the microbiota to low molecular 
weight, phenolic acids, and is a well-characterised molecule 
[22, 23]. We hypothesized that the colonic metabolism of 
(poly)phenols would be less efficient in older adults.
Methods
Study design
Two designs were utilised to test the study hypothesis. The 
first employed a human dietary intervention to compare 
the colonic metabolism of (poly)phenols between healthy 
younger (< 45 years) and older (> 50 years) adults, focusing 
on urinary phenolic acid excretion and gut bacterial com-
position (focusing on known polyphenol-degrading bacte-
ria). The age cut-off, while arbitrary, was designed to obtain 
two groups distinct in age. The National Health Service in 
Scotland uses the age of 50 years as the cut-off for their 
bowel screening programme, justified by the increased risk 
of colonic diseases in this age group [42]. The second design 
employed an in vitro fermentation model, using faecal sam-
ples collected during the dietary intervention, to study the 
metabolic (functional) capacity of the faecal microbiota 
according to age when a specific flavonol, rutin (querce-
tin-3-O-rutinoside), was fermented.
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Subjects and recruitment
Older (≥ 50 years) and younger (< 45 years) adults were 
recruited using local advertisements, printed poster dis-
plays, and online social networking sites. Exclusion cri-
teria included consuming alcohol (> 4 units/day), obesity 
(BMI > 30 kg/m2), taking dietary supplements, pregnancy or 
risk of pregnancy, smoking, taking any medication, or hav-
ing any conditions known to affect bowel function. Approval 
for this study was obtained from the Ethics committee of the 
University of Glasgow, College of Medical; Veterinary & 
Life Sciences (ref FM03110). All participants gave informed 
written consent.
Sample size and power calculation
The sample size was calculated with GPower version 3.1 
(Dusseldorf university) using urinary phenolic acid excre-
tion as a primary outcome. In younger adults [43], selected 
urinary phenolic acid excretion increased from 20.6 ± 7.6 to 
62.7 ± 44.3 µmol/day after a high-polyphenol diet (∆ high-
low diet 42.2 ± 41.0). Pilot analyses showed that excretion 
varied between ethnic subgroups, with a difference for the 
∆ high-low diet of 59 µmol/day between groups (Cauca-
sian ∆ high-low 60.5 ± 36.0 µmol/day; Asian ∆ high-low 
diet 1.5 ± 10.2 µmol/day; groups with unmatched numbers 
d = 1.6). Assuming a similar effect size of d = 1.6, a total of 
n = 16 participants is sufficient to detect (or not) a similar 
difference (β = 80%, two tails, α = 0.05). Based on previous 
experience with similar trials, we allowed for a 40% drop-
out rate to recruit a sample of n = 13 individuals per group. 
While recruitment in the older group reached n = 13, this 
was not the case for the younger group (n = 8)—as such, 
the a priori power of the study to detect an effect size of 
1.33 is 80% (and 92% for d = 1.6) given the sample size and 
allocation.
Measurements and sample collection
Anthropometric measurements height, weight, body mass 
index (BMI), and waist circumference (WC), and blood 
pressure (BP) were collected at baseline and all subsequent 
appointments using standard techniques [44]. All partici-
pants followed two 3-day diets separated by a 1 week wash-
out: a low-polyphenol diet (LPD, avoiding all fruits, veg-
etables, onions, coffee, tea, chocolate, vanilla and similar 
flavourings, whole meal products, alcohol, spices, and all 
dietary supplements) and a high-polyphenol diet (HPD, 
including flavonoid-rich foods including tomatoes, plums, 
provided along with cooking guidance and recipes) (Sup-
plementary Table 1). The phenolic composition and fibre 
content of the HPD are available in Supplementary Table 2. 
Urine (24 h) was collected on the last day of each diet, and a 
morning stool sample was collected at the end of the 3-day 
diet.
Bowel movements
The usual frequency of bowel movements (twice daily or 
more, daily, every 2–3 days or less than twice a week) was 
self-reported retrospectively at the beginning of the study.
Dietary assessment of (poly)phenol intake
Prospective, weighed dietary records were kept by partici-
pants throughout each study period. Diaries were analysed 
using the WinDiets Nutritional Analysis Software (Robert 
Gordon University, Aberdeen, UK) [45]. The mean flavo-
noid content of foods was sourced from the Phenol-Explorer 
database (http://www.pheno l-explo rer.eu/conte nts) [46]. The 
flavonoid content of low-polyphenol foods such as pasta, 
bread, biscuits, cakes and pastry was estimated from their 
wheat flour content [47].
In vitro fermentation (faecal incubation)
The faecal incubation was prepared as previously described 
[48]. The substrates used were (a) control (no substrate), 
(b) 28 µM rutin, and (c) 28 µM rutin (Sigma–Aldrich Com-
pany Ltd; Dorset, UK) with 1 g raftiline HP (Orafti, Tienen, 
Belgium). Raftiline (fibre) was added to the fermentation 
medium as a source of energy (carbon) to help mimic in vivo 
conditions (compared to fermentations without a source of 
carbon or a fast-fermented source such as glucose).
Freshly voided human faecal samples were homogenised 
with sodium phosphate buffer (0.1 M, pH 7.0) in a blender 
(Braun™) to make a 32% faecal slurry (16 g faecal sam-
ple with 50 ml sodium phosphate buffer). The faecal slurry 
(5 ml) was added to 44 ml of fermentation medium in 100 ml 
glass sterilised bottles. The substrate (rutin, 28 µmols) was 
added to the faecal slurry with or without 1 g of a highly 
fermentable fibre (raftiline). Control cultures containing 
no substrates were incubated at the same time. Participants 
were asked to provide a whole bowel movement, and the 
same sample was used to produce the faecal slurry added to 
the four fermentation bottles (a single bottle for each condi-
tion). The anaerobic conditions were established by using 
anaerobic reagents in the media (reducing solution checked 
with resazurin) and by flushing the media and bottles with 
oxygen-free nitrogen. The fermentation bottles were sealed 
with a gas-tight septum, which was fitted with a gas col-
lection syringe monitoring gas production. Fermentation 
bottles were kept upright in a shaking water bath at 37 °C, 
60 strokes/min for 24 h to simulate the colonic lumen condi-
tions. Two samples (3 ml) of fermentation fluid were col-
lected after 0, 2, 4, 6 and 24 h. One sample for each time 
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point was immediately stored at − 80 °C for phenolic acid 
analysis. The other was mixed with 1M NaOH (1 ml) and 
stored at − 20 °C for SCFA production measurements.
Colonic fermentation markers: pH and gas 
production
A 50-ml disposable syringe and a three-way tap were used to 
measure gas production in each fermentation bottle at differ-
ent time points (0, 2, 4, 6, 24 h). An auto-calibrated portable 
digital pH meter model (Hanna pH20 instruments, USA) 
was used to measured faecal pH by preparing a suspension 
of ~ 1 g faecal sample from each participant and diluted in 
3 mL of distilled water. The pH of fermentation fluid was 
determined at 0, 2, 4, 6, and 24 h with universal pH indicator 
paper from 1 to 14 (Fisher Brand, UK).
Phenolic acid extraction, derivatization and analysis 
by gas chromatography mass spectrometry (GC–MS)
Phenolic acids were measured in urine and fermentation 
fluid. Extraction and derivatisation were carried out as pre-
viously described [43]. Derivatized phenolic acids were ana-
lysed on a Trace GC interfaced to a DSQ mass spectrom-
eter equipped with a split/splitless injector and an AI3000 
autosampler (Thermo Fisher, Hemel Hempstead, UK) as 
previously described [42]. Identification of phenolic acids 
was based on retention time (tR) and target ions [49]. Quan-
tification was based on 2.5 to 15 µg calibration curves of 
derivatised and analysed phenolic acid standards. The area 
ratio of each standard was averaged and the coefficient of 
variance calculated (R2 > 0.98).
SCFA analysis by gas chromatography with flame 
ionization detection (GC‑FID)
Short chain fatty acids were measured in dry faeces and fer-
mentation fluid. Extraction and analysis were carried out 
according to Laurentin and Edwards [50]. SCFAs were esti-
mated using a TRACE™ 2000 gas chromatograph (Thermo 
Quest Ltd, Manchester, UK) equipped with a flame ioniza-
tion detector (250 °C) and a Zebron ZB-Wax capillary col-
umn (15 m × 0.53 mm id × 1 µm film thickness, catalogue 
No.7 EK-G007 22, Phenomenex, Cheshire, UK). EK-G007 
22, Phenomenex, Cheshire, UK).
Extraction, concentration, and purity of bacterial 
DNA
Bacterial DNA was isolated and purified as previously 
described [51]. DNA concentration and purity were deter-
mined by measuring 1.5 µl of undiluted DNA extract with 
a NanoDrop ND-1000 (software version 3.7.4; Fisher 
Scientific, UK). An absorbance ratio (A260/A280) greater 
than 1.8 was used to assess high purity, and the absorbance 
ratio at 230/260 nm was used to assess guanidinium salt 
carried. Furthermore, DNA was assessed for shearing by 
electrophoresis.
Determination of bacterial diversity 
and composition
Flavonifractor plautii was selected for quantification in fae-
cal samples because of its previous reported contribution to 
the colonic metabolism of flavonoids [52–54]. Bifidobacte-
ria, bacteroides, and total bacteria were also measured. Real-
time PCR with species-specific probes was used to quantify 
individual species, bacterial populations, and total bacteria 
(Supplementary Methods) on a 7500 Real-Time PCR System 
(Applied Biosystems, Carlsbad, CA) using TaqMan. Quan-
tification was performed against serial dilution of bacterial 
DNA standards obtained from pure cultures (Supplemen-
tary Methods). DNA standards for F. plautii (DSM 4000; 
6.3 ng/µl) were obtained from the German Collection of 
Microorganisms and Cell Cultures (DSMZ). Standard DNA 
for bifidobacteria (Bifidobacterium longum, DSM 20219T, 
9.8 ng/µl), bacteroides [Bacteroides vulgatus (DSM 1447T, 
27.2 ng/µl)], and total bacteria [Bacteroides vulgatus (DSM 
1447T, 27.2 ng/µl)] were available in-house [51]. A set of 
seven bacterial reference standards were prepared for each 
target. The serial dilution to measure the Eubacterium ramu-
lus and F. plautii was 1:5, and 1:10 to measure bifidobacte-
ria, bacteroides, and total bacteria.
Statistical analysis
Data were analysed using Minitab 16. The Anderson–Dar-
ling test was used for normality. Descriptive statistics are 
presented as mean and standard deviation, or medians and 
inter quartile range (IQR). Comparisons between groups 
were carried out using Mann–Whitney test for non-paramet-
ric data and paired test and two sample t tests for normally 
distributed data. Chi-squared test was used to compare the 
frequency of bowel movement between groups.
Results
Subject characteristics
13 older adults aged between 51 and 76 years old and eight 
younger adults aged between 23 and 43 years old were 
recruited, with no subsequent drop-out. The baseline data 
for participants are presented in Table 1, with no significant 
differences in anthropometric characteristics between the 
two groups. Median BMI and WC were within the normal 
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cut-off range for younger and older healthy adults. The male 
to female ratio was similar between groups, with two males 
and six females in the younger group and three males and ten 
females in the older adult group (p = 0.99). Diastolic BP was 
higher (by 17 mmHg) in older adults (p = 0.005).
Frequency of bowel movements was not different 
between younger and older groups (p = 0.84) with 37.5% 
in the younger group and 25% in the older group having 
twice daily or more frequent bowel movement; 37.5% in 
the younger group and 50% in the older group having daily 
bowel movement; and 25% in the younger group and 25% in 
the older group having a bowel movement every 2–3 days.
Flavonoid intake during low‑ and high‑polyphenol 
diets (LPD and HPD)
Flavonoid intake during the 3-day LPD was 6 mg/day in 
the younger (IQR 2–10) and older groups (IQR 2–16). Dur-
ing the 3-day HPD, flavonoid intake in younger adults was 
510 mg/day (IQR 499–539) and 496 mg/day (IQR 438–540) 
in older adults. Flavonoid intake increased from low to high 
diet for both groups (p = 0.000), with no difference between 
groups (Fig. 1). Moreover, there were no differences between 
the groups in term of flavonols or phenolic acids intake after 
the HPD (Supplementary Table 3). As urinary phenolic acid 
excretion has been shown to be markedly increased between 
8 and 24 h following ingestion [31], urinary phenolic acid 
excretion was corrected for flavonoid intake on day 3 of the 
diet, given that the 24 h urine collection was carried out 
from the second urine of day 3, and including the first urine 
of day 4.
There was no difference between groups for intake on 
day 3, during the LPD [5 mg (IQR 2–10) versus 9 mg (IQR 
5–21) for younger and older groups, respectively] or the 
HPD [553 mg (IQR 474–666) versus 497 mg (IQR 305–643) 
for younger and older groups, respectively].
Dietary fibre intake during low‑ 
and high‑polyphenol diets (LPD & HPD)
The fibre intake increased after the HPD in both groups 
(younger: p = 0.0009; older: p = 0.002) with no difference 
between groups in terms of change to dietary fibre intake 
(p = 0.6). Dietary fibre intake during the 3-day LPD was 
9 g/day (IQR 8–10) in the younger and 12 g/day in the older 
group (IQR 8–14). During the 3-day HPD, dietary fibre 
intake in younger adults was 27 g/day (IQR 26–29) and 27 g/
day (IQR 24–34) in older adults (Supplementary table 4).
Macronutrient/ micronutrient intake during low‑ 
and high‑polyphenol diets (LPD and HPD)
There was no difference between groups in terms of energy, 
fat, protein, carbohydrate, total sugars, starch, or alcohol 
intake during either low or HPD, or when considering the 
difference in macronutrient intake between dietary periods 
(Δ high-low diet) (Supplementary Table 4). The intake of 
vitamins or dietary minerals did not differ either, except for 
thiamine and copper intake during the HPD, with thiamine 
intake higher (1.3-fold; p = 0.05) in the older group, and cop-
per intake higher (1.4-fold; p = 0.01) in the younger group 
(Supplementary Table 5).
Table 1  Baseline data in younger (n = 8) and older (n = 13) participants
*p value using Fisher’s exact test between age group
a BMI cut-off points of overweight [adult = 25, older adult (55–65 years old) = 28]; [55, 56]
b WC cut-off points of high risk (adult women = 80 cm, men = 94 cm; older women = 99 cm, men = 106 cm); [55, 56]
Younger group (n = 8) Older group (n = 13) p value
Median IQR Median IQR
Age (years) 23.0 22.0–28.5 61.0 54.0–64.0 0.0002
Height (cm) 163.0 155.3–174.3 161.0 1.6–1.7 0.3
Weight (kg) 63.0 56.4–69.8 63.0 59.4–75.7 0.4
BMI (kg/m2)a 22.0 20.6–26.4 25.1 23.8–28.4 0.06
WC (cm)b 80.0 77.8–80.8 85.0 79.0–98.0 0.1
Systolic BP 122.0 108.5–127.5 120.0 117.0–137.0 0.2
Diastolic BP 69.0 59.8–73.5 86.0 75.0–89.0 0.005
n % n %
Sex (M/F) 2/6 – 3/10 – 0.99*
Normal weight 5 62.5 6 46.1 0.68*
Overweight 3 37.5 7 53.8 –
Obese 0 0 0 0 –
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Identification of phenolic acids in urine
A total of 18 urinary phenolic acids were identified and 
quantified by GC-MS after LPD and HPD in the younger 
group. However, 4-OHPAA was excluded from the sum of 
urinary phenolic acid excreted for between-group compari-
sons, as it is produced by pathways unrelated to the colonic 
degradation of (poly)phenols [31] and did not increase in 
young or older adults after the HPD. Subsequently, only 
n = 17 phenolic acids are reported (Table 2).
Urinary phenolic acid excretion after low‑ 
and high‑polyphenol diets (LPD and HPD)
The sum of the 17 urinary phenolic acids excreted 
increased  ~ 5.6-folds in the younger group from 205 µmol/
day (IQR 158–525) after the LPD to 1197 µmol/day (IQR 
730–1345) after the HPD (p = 0.0009), and ~ 5.5-fold in 
the older group, from 336 µmol/day (IQR 190–469) to 
1819 µmol/day (IQR 986–2831) respectively (p = 0.0002). 
The change in urinary excretion (Δ high-low diet) was not 
different between groups; however, the urinary phenolic 
acid excretion was higher after the HPD in the older group 
(p = 0.04) compared to the younger group (Fig. 2), with a 
large variability in urinary PA excretion in the older group. 
Correcting for flavonoid intake did not reveal further differ-
ence in differential excretion between the groups. Based on 
the key (statistical) differences seen between LPD and HPD, 
the main phenolic acids linked to rutin metabolism that are 
excreted in urine, by at least threefold, are 3-OHPAA, HVA, 
3,4DOHPAA, 3,4 DIOHPPA, and 3-OHhippA.
Hippuric acid (HA) was always the most abundant acid in 
urine samples in both groups (80 and 98% of total phenolic 
acids for younger and older groups, respectively), and was 
higher in the older group after the HPD (2.7-fold; p = 0.03) 
compared to LPD. However, the change in excretion, Δ high-
low diet, was not different between groups.
The sum of urinary phenolic acids minus HA was consid-
ered (as HA is most likely to be formed in the liver by conju-
gation of benzoic acid and glycine, rather than from flavonoid 
metabolism). The sum of PA excreted after the HPD increased 
in both groups (compared to LPD), ~ twofold in the younger 
group, from 104 µmol/day (IQR 91–129) to 211 µmol/day 
(IQR 146–233) (p = 0.003) and in the older group, from 
56 µmol/day (IQR 48–77) to 100 µmol/day (IQR 78–127) 
(p = 0.007). The difference in urinary excretion (Δ high-low 
diet) remained similar between groups. However, urinary phe-
nolic acid concentration was higher after the LPD (p = 0.03) 
and HPD in the younger group (p = 0.02); Fig. 3.
Most notably, there were important qualitative and quan-
titative differences between groups for the excretion of 
individual phenolic acids (∆ high-low diet). While 17 phe-
nolic acids were identified in all younger participants after 
both diets, only eight phenolic acids were excreted by all 
older participants (BA, MA, 3-OHPAA, HVA, 4-OHMA, 
3,4diOHPAA, HA, 3-OHhippA) (Table  2). A narrower 
range of urinary phenolic acids (n = 8–16) was detected in 
most (n = 9/13) older participants. The older group excreted 
19-fold less BA (p = 0.03), and 4.5-fold less VA (p = 0.04) 
than the younger group (Table 2).
Faecal pH after low‑ and high‑polyphenol diets (LPD 
and HPD)
After the HPD, the faecal pH significantly decreased in the 
older group from 7.7 (IQR 7.4–7.9) to 6.9 (IQR 6.7–7.4; 
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p = 0.006), but not in the younger group (7.2, IQR 6.9–7.5 
to 6.7, IQR 6.4–7.1). Looking at pH changes with diet (Δ 
high-low diet for pH), there was no significant difference 
between the groups (Supplementary Fig. 1).
Faecal SCFA after the low‑ and high‑polyphenol 
diets (LPD and HPD)
Total faecal SCFA concentration (sum of all SCFA) did 
not change significantly from low to HPD in either group 
despite a threefold increase in fibre intake [younger from 
164 µmoles/g dwt (IQR 124–218) to 192 µmoles/g dwt (IQR 
162–214); older from 258 µmoles/g dwt (IQR 168–280) to 
265 µmoles/g dwt (IQR 208–301)]. Although there were 
no significant differences (Δ high-low diet) between the 
groups, the mean SCFA concentration was 1.4 fold higher 
in the older group compared to the younger group after the 
HPD (p = 0.01; Supplementary Fig. 2). There were no dif-
ferences in the changes (Δ high-low diet) in each specific 
acid between groups. However, the absolute levels of acetic 
0
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Fig. 2  24-hour urinary phenolic acid profile excretion (µmol/day) 
after low and high-polyphenol diets in younger (n = 8) and older 
(n = 13) participants. Each circle indicates the measurement of the 
urinary phenolic acids profile for each participant after low and high-
polyphenol diets. Median urinary phenolic acids for each group are 
indicated by a red horizontal line. a, b symbols indicate differences 
within group (LPD to HPD; younger: p = 0.0009; older: p = 0.0002). 
§Symbol indicates differences between groups (HPD vs. HPD; 
p = 0.04)
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Fig. 3  24-hour urinary phenolic acid profile excretion without hippu-
ric acid (µmol/day) after low- and high-polyphenol diets in younger 
(n = 8) and older (n = 13) participants. Each circle indicates the meas-
urement of the urinary phenolic acids profile without hippuric acid 
for each participant after low- and high-polyphenol diets. Median 
urinary phenolic acids profile without hippuric acid for each group 
is indicated by a red horizontal line. a,b symbols indicate differences 
within group (LPD to HPD; younger: p = 0.003; older: p = 0.007). 
†Symbol indicates differences between groups (LPD vs. LPD; 
p = 0.03). §Symbol indicates differences between groups (HPD vs. 
HPD; p = 0.02)
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acid were higher after both the LPD (1.5-fold; p = 0.01) 
and HPD (1.4-fold; p = 0.02) in the older group, compared 
to the younger group. Absolute levels of heptanoic acid 
were higher after the HPD in the younger group (1.8-fold; 
p = 0.03; Supplementary Table 6).
Concentration of bacterial DNA isolated from faecal 
samples after LPD and characteristics of the qPCR 
run condition
High quality and high yield DNA was obtained from all fae-
cal samples. The purity and yield of the extracted DNA was 
high (1.7–2.0 absorbance ratio 280/260 nm; yield 463 ng/
µL (IQR 429–552) for older group samples, 519 ng/µL (IQR 
480–576) for the younger group samples). The faecal DNA 
appeared intact and compact as a high-molecular-weight 
band when electrophoresed through a 1.5% agarose gel. The 
qPCR amplification efficiency was within the normal range 
(90–105%) for the total bacteria, Bacteroides–Prevotella, 
and Flavonifractor plautii in both groups; however, effi-
ciency for Bifidobacterium spp. was just below the normal 
range (87%) in both groups. The coefficient of determination 
(R2) range was between 0.994 and 0.999 for all bacterial 
groups and species in both groups. Absolute levels of bifi-
dobacteria, bacteroides, and Flavonifractor plautii did not 
differ between younger and older groups (Table 3).
In vitro fermentation of rutin
Ten fermentations were carried out using the stool samples 
of six younger (one male and five females) and four older 
subjects (one male and three females), collected after the 
LPD. Rutin was fermented for 24 h with or without fibre 
(raftiline) to test the metabolic capacity of the gut faecal 
contents, including the microbiota, in relation to ageing. 
There was no change in the pH of the fermented faecal flu-
ids containing rutin alone, over time, in either group (Sup-
plementary Fig. 3). However, raftiline and the combination 
of rutin + raftiline reduced pH from 7 to 5 by 24 h, in both 
groups. There was no difference in total gas production 
between groups after 24 h. In both younger and older groups, 
the combination of rutin + raftiline increased gas produc-
tion more than rutin alone (p = 0.02; p = 0.03; respectively). 
Moreover, the older group produced 1.9-fold more gas over 
24 h fermentation than the younger group when raftiline was 
fermented alone (p = 0.02; Supplementary Table 7).
Metabolism of rutin in faecal fluids and phenolic 
acids formation
Seven phenolic acids were detected in fermentations of 
rutin with faecal samples from younger and older adults, Ta
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over 24 h, with great variability within and between groups 
(Table 4).
Only PAA and 3-OHPPA were detected in all fermen-
tations, while 3-OHPAA (younger: 5/6; older 3/4) and 
4-OHPPA (younger: 5/6; older 4/4) were detected in most 
fermentations. 3,4diOHPAA, a recognised rutin metabo-
lite, was seen in all younger donors and most older donors 
(younger: 6/6; older 3/4). Finally, 4-OHBA (younger: 1/6; 
older 2/4) and 3,4diOHPPA (younger: 2/6; older 2/4) were 
detected in the fermentations of some donors only. Five 
of these phenolic acids were also detected in the control 
fermentation at 0 h: PAA was detected in all younger and 
older donors; however, 4-OHPPA (younger: 2/6; older 3/4), 
3-OHPPA (younger: 2/6; older 4/4), 4-OHBA (older only 
2/4), and 3-OHPAA (younger only 1/6) were detected in the 
fermentations of some donors (Table 4).
The sum of the seven phenolic acids increased over time 
in all rutin fermentations, with or without raftiline in the 
younger group (35-fold with rutin only, p = 0.000, sixfold 
with rutin + raftiline, p = 0.001) and in the older group when 
rutin was fermented alone (21-fold, p = 0.04), without signif-
icant increase with the addition of raftiline (ninefold change, 
p = 0.06). There was no difference in the sum of the seven 
acids between groups after 24 h in all rutin fermentations, 
with or without raftiline. The addition of raftiline to the fer-
mentation inhibited the formation of all seven phenolic acids 
after 24 h, by sevenfold (p = 0.02) in the younger group and 
2.8-fold (p = 0.33) in the older group with no detectable dif-
ference between groups (Fig. 4).
Individual phenolic acids formed 
after the fermentation of rutin
PAA increased over time in the fermented faecal fluids 
from the younger group with rutin (25-fold; p = 0.000) and 
rutin + raftiline (2.1-fold; p = 0.03), and in the fermented 
faecal fluids from the older group with rutin only (19-fold; 
p = 0.04) but not with the addition of raftline. The older 
group formed more PAA in the fermentations of rutin + raf-
tiline (threefold; p = 0.01) and raftiline only (fourfold; 
p = 0.03) compared with the younger group but no differ-
ences were detected between groups when rutin alone was 
fermented. 3-OHPPA also increased in the fermented fae-
cal fluids containing rutin only in both younger (13-fold, 
p = 0.02) and older (25-fold, p = 0.03) groups, with no dif-
ferences between the groups (Table 4).
Metabolism of rutin in and SCFA production faecal 
incubation
Total SCFA concentrations increased over time in the 
fermentations of rutin + raftiline (38-fold for the younger 
group, p = 0.005; 58-fold for the older group, p = 0.03) and 
rutin only (13-fold for younger group, p = 0.005; 14-fold 
for the older group, p = 0.03) with no differences between 
groups. Acetic and propionic acid did not differ between the 
groups but butyric acid concentration was higher in the older 
group (two-fold; p = 0.009) at 24 h (Supplementary Table 8).
Discussion
This study tested the hypothesis that age influences the 
metabolism of dietary (poly)phenols, which may be relevant 
for gut health and the development of chronic diseases. To 
our knowledge, this is the first dietary semi-controlled study 
investigating the colonic metabolism of dietary polyphenols 
in different age groups using human feeding and in vitro 
faecal fermentation designs. 3 days on each diet was enough 
for (poly)phenol-rich foods to be supplied to the colon and 
be fermented over the course of several meals. The present 
study showed:
1. Inter and intra variability in younger and older groups in 
terms of urinary excretion of phenolic acids after LPD/
HPD.
2. Limited differences between groups in phenolic acid 
formation after fermentation of rutin with in vitro batch 
faecal incubations.
Previous work compared absorption, metabolism, and 
excretion of epicatechin in healthy younger and older sub-
jects, with limited differences in flavonol metabolites lev-
els in plasma and 24-h urinary collection between the age 
groups [34]. Our own results align with these findings, 
showing limited quantitative differences between groups in 
term of phenolic acid excretion, as catabolites of (poly)phe-
nolics or colonic metabolism capacity. These same findings, 
however, highlight important qualitative differences between 
the two age groups. While all younger participants excreted 
all 17 phenolic acids in urine after the 3-day high-polyphe-
nols diet, not all older participants excreted the full panel. 
This varied from one participant excreting 8 out of 17 phe-
nolic acids to another excreting 17 out of 17 phenolic acids. 
This is particularly relevant as inter-individual variability 
in the response to (poly)phenolics (including flavonols) is 
now being increasingly considered [61]. However, whether 
inter-individual variability of (poly)phenols metabolism sug-
gests a biological difference between the age groups is still 
unclear.
The phenolic acids consistently seen in urines from 
both younger and old subjects were BA, MA, 3-OHPAA, 
HVA, 4-OHMA, 3,4diOHPAA, HA, and 3-OHhippA 
with 3-OHPAA, HVA, and 3,4diOHPAA, well described 
rutin metabolites [27, 48]. Intermediates (3,4-diOHBA, 
3,4-diOHPAA, 3,4-diOHPPA) were detected in variable 
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Table 4  Accumulation of seven phenolic acids (µmol/L) after 0, 6, and 24 h of fermentation in faecal fluids from younger (n = 6) and older 
(n = 4) groups
Phenolic  acida Group Substrates 0 h 6 h 24 h
Median IQR (Q1−Q3) Median IQR (Q1−Q3) Median IQR (Q1−Q3)
PAA [59] Younger Blank 3.7 (n = 6/6) 3.0–4.0 15.2 (n = 6/6) 6.0–28.1 66.1 (n = 6/6) 46.8–72.2
Raftiline 2.7 (n = 6/6) 2.9–5.2 8.6 (n = 6/6) 7.4–8.8 6.6 (n = 6/6) 6.9–10.6
Rutin 3.3 (n = 6/6) 2.3–3.9 6.0 (n = 6/6) 3.5–11.3 81.9 (n = 6/6) 44.4–95.5
Rutin + raftiline 4.3 (n = 6/6) 2.5–3.2 8.6 (n = 6/6) 5.3–9.8 8.6 (n = 6/6) 3.9–10.1
Older Blank 6.9 (n = 4/4) 6.2–7.7 92.8 (n = 4/4) 38.7–138.2 88.8 (n = 4/4) 81.4–101.4
Raftiline 7.0 (n = 4/4) 4.4–9.5 22.2 (n = 4/4) 15.8–42.1 26.6 (n = 4/4) 18.4–44.7
Rutin 6.7 (n = 4/4) 4.2–8.8 58.7 (n = 4/4) 12.7–110.8 128.3 (n = 4/4) 93.4–147.3
Rutin + raftiline 6.4 (n = 4/4) 3.8–8.6 17.5 (n = 4/4) 9.1–42.0 25.3 (n = 4/4) 18.9–40.8
3-OHPAA [48, 57, 
59]
Younger Blank 0.2 (n = 1/6) – 0.2 (n = 1/6) – 0.5 (n = 2/6) 0.4–0.6
Raftiline 0.3 (n = 1/6) – 0.2 (n = 1/6) – 0.1 (n = 1/6) –
Rutin 0.2 (n = 1/6) – 1.5 (n = 2/6) 1.1-2.0 4.4 (n = 5/6) 10.4–24.3
Rutin + raftiline 0.1 (n = 1/6) – 1.3 (n = 1/6) – 1.3 (n = 2/6) 0.9–1.7
Older Blank ND – 0.1 (n = 1/4) – 0.1 (n = 1/4) –
Raftiline ND – ND – ND –
Rutin 0.1 (n = 1/4) – 0.8 (n = 2/4) 0.5–1.1 4.2 (n = 3/4) 3.2–29.8
Rutin + raftiline ND – 0.3 (n = 3/4) 0.2–1.2 0.6 (n = 3/4) 0.4–0.8
4-OHBA [48, 57] Younger Blank ND – ND – ND –
Raftiline ND – 0.1 (n = 1/6) – 0.1 (n = 1/6) –
Rutin 0.1 (n = 1/6) – 0.1 (n = 1/6) – 0.1 (n = 1/6) –
Rutin + raftiline ND – 0.1 (n = 1/6) – 0.1 (n = 1/6) –
Older Blank 0.2 (n = 2/4) 0.2–0.2 0.4 (n = 3/4) 0.3–12.2 0.3 (n = 3/4) 0.2–13.8
Raftiline 0.2 (n = 1/4) – 0.2 (n = 1/4) – 0.1 (n = 1/4) –
Rutin 0.3 (n = 2/4) 0.1–0.3 0.2 (n = 2/4) 0.1–0.2 0.2 (n = 2/4) 0.1–0.2
Rutin + raftiline 0.2 (n = 2/4) 0.1–0.2 0.3 (n = 2/4) 0.2–0.2 0.4 (n = 2/4) 0.3–0.4
3-OHPPA [27, 60] Younger Blank 1.6 (n = 2/6) 1.2–2.0 2.8 (n = 3/6) 1.6–3.0 2.9 (n = 3/6) 1.7–3.3
Raftiline 0.5 (n = 3/6) 0.4–1.8 0.9 (n = 5/6) 0.7–1.2 1.3 (n = 5/6) 1.2–2.6
Rutin 0.4 (n = 4/6) 0.3–1.1 1.8 (n = 5/6) 1.1–1.9 4.8 (n = 6/6) 2.0–10.0
Rutin + raftiline 0.4 (n = 3/6) 0.4–1.3 1.6 (n = 4/6) 0.5–5.0 1.2 (n = 5/6) 0.8–3.4
Older Blank 0.9 (n = 4/4) 0.6–1.7 4.2 (n = 4/4) 0.6–8.2 3.4 (n = 4/4) 2.2–4.9
Raftiline 1.0 (n = 4/4) 0.6–2.9 2.8 (n = 4/4) 1.0–5.0 3.4 (n = 4/4) 2.7–4.1
Rutin 0.5 (n = 4/4) 0.4–1.3 7.7 (n = 4/4) 1.6–25.1 13.4 (n = 4/4) 11.7–20.1
Rutin + raftiline 1.3 (n = 4/4) 0.5–2.3 9.5 (n = 4/4) 1.6–22.4 9.4 (n = 4/4) 3.0-18.9
4-OHPPA [57] Younger Blank 0.4 (n = 2/6) 0.3–0.6 6.5 (n = 4/6) 3.6–10.3 1.2 (n = 4/6) 0.8–3.4
Raftiline 0.6 (n = 2/6) 0.4–0.6 3.8 (n = 4/6) 2.9–4.1 3.9 (n = 4/6) 3.1-4.0
Rutin 0.5 (n = 2/6) 0.3–0.6 1.1 (n = 4/6) 0.9–1.7 4.9 (n = 5/6) 1.6–7.7
Rutin + raftiline 0.5 (n = 1/6) – 1.0 (n = 3/6) 0.9–2.2 1.2 (n = 3/6) 1.0–2.0
Older Blank 0.4 (n = 3/4) 0.2–0.8 3.4 (n = 3/4) 1.8–14.6 21.6 (n = 4/4) 10.3–37.6
Raftiline 0.3 (n = 3/4) 0.2–0.9 1.4 (n = 3/4) 0.9–1.4 2.0 (n = 3/4) 1.3-2.0
Rutin 0.8 (n = 4/4) 0.3–1.3 1.6 (n = 4/4) 1.3–2.1 6.9 (n = 4/4) 5.0-14.2
Rutin + raftiline 0.3 (n = 3/4) 0.2–0.9 0.4 (n = 3/4) 0.4–0.7 1.9 (n = 3/4) 1.4–4.6
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amounts at different time points, but the absence of these 
phenolic acids at any given point does not simply illus-
trate capacity, but also the kinetics in flavonol catab-
olism. The evidence in this study and that of others is 
clearest 3-OHPAA and 3,4-diOHPAA, as they are both 
found in the in vivo and in vitro studies. Three more, 
HVA, 3,4-diOHPPA, and 3-OHhippA were present in the 
in vivo study after the HPD in both age groups, but not in 
Table 4  (continued)
Phenolic  acida Group Substrates 0 h 6 h 24 h
Median IQR (Q1−Q3) Median IQR (Q1−Q3) Median IQR (Q1−Q3)
3,4diOHPAA [48, 59] Younger Blank ND – ND – ND –
Raftiline ND – ND – ND –
Rutin ND – 16.1 (n = 6/6) 8.7–35.9 32.9 (n = 6/6) 5.5–62.4
Rutin + raftiline 0.2 (n = 1/6) – 5.0 (n = 6/6) 1.7–32.1 7.1 (n = 6/6) 2.9–32.9
Older Blank ND – ND – ND –
Raftiline ND – ND – 3.2 (n = 1/4) –
Rutin 0.3 (n = 1/4) – 63.0 (n = 3/4) 32.0–66.3 65.8 (n = 3/4) 35.4–79.1
Rutin + raftiline 0.5 (n = 1/4) – 48.3 (n = 3/4) 24.8–48.7 52.0 (n = 3/4) 27.1–53.0
3,4diOHPPA [59] Younger Blank ND – ND – ND –
Raftiline ND – ND – ND –
Rutin ND – 0.2 (n = 1/6) – 0.4 (n = 2/6) 0.4–0.5
Rutin + raftiline Nd – ND – ND –
Older Blank Nd – ND – ND –
Raftiline Nd – ND – ND –
Rutin 0.2 (n = 1/4) – 1.1 (n = 2/4) 0.5–1.6 0.5 (n = 2/4) 0.4–0.4
Rutin + raftiline ND – ND – 0.6 (n = 1/4) –
PAA phenylacetic acid; 3-OHPAA 3-hydroxyphenylacetic acid; 3-OHPPA 3-hydroxyphenylpropionic acid; 4-OHBA 4-hydroxybenzoic acid; 
4-OHPPA 4-hydroxyphenylpropionic acid; 3,4diOHPAA 3, 4-dihydroxyphenylacetic acid; 3,4diOHPPA 4-hydroxy-3-methoxy-phenylpropionic 
acid; ND not detected
a Phenolic acids previously described in the literature
Fig. 4  Sum of all (n = 7) phenolic acids (µmol/L) in fermented faecal 
fluids from older (n = 4) and younger (n = 6) adults (over 24 h of fer-
mentation). The white boxes represent  t = 0 h, the light shaded boxes 
t= 6  h and the dark shaded boxes, t = 24  h. Boxes representing the 
older group are labelled “O”, boxes representing the younger group 
are labelled “Y”. #There was a statistically significant increase in the 
sum of PA in younger adults over time in the blank fermentations 
(p < 0.001) and when rutin and raftiline were combined (p = 0.001). § 
There was a statistically significant increase in the sum of PA in older 
adults over time in the fermentations with rutin alone (p = 0.04)
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the in vitro fermentations—highlighting the likely role of 
phase II metabolism in the liver in the synthesis of these 
compounds. However, VA, GA, 4-OHMA, 3,4-diOHBA 
which were present in all younger participants, but only 
in some of the older participants, could be linked to age-
related variations.
With their simpler structure and increased bioavail-
ability, phenolic acids are one of the major (poly)phenol 
metabolites present in blood with a maximum plasma con-
centration of 0–4 µmol/L with an intake of 50 mg agly-
cone equivalents [62], and reported anti-inflammatory, 
anti-carcinogenic, anti-proliferative, anti-glycative and 
prebiotic properties in in vitro and/or in vivo studies [16, 
62–65]. As the concentration in the colon is much higher 
than in the circulation with concentration ranging from 
46 to 479 µmol/L in human faecal water [59, 66], some 
effects exerted at high doses may still be physiological 
[67]. Moreover, while phenolic acid intake is usually in 
the range of 50–900 mg per day, phenolic acids in urines 
can reach levels close to 1 mmol/day—as urinary phenolic 
acid largely come from the colonic metabolism of (poly)
phenolics, but also other compounds such as benzoic acid 
and precursors (quinic acid, aromatic amino acid trypto-
phan, tyrosine, and phenylalanine). Other sources of ben-
zoic acid are benzoates (E numbers 210–219) which are 
commonly used in food, medications, and mouthwashes 
[68, 69].
The bioactivity of specific phenolic acids is less well 
defined, with examples including 3,4diOHPAA an inhibi-
tor of enzymes involved in detoxification (GSTT2), inflam-
mation (COX-2) and anti-proliferative activity in HCT-
116 colon cancer cells [67, 70]; 3,4-diOHPPA (3 µM) and 
3,4-diOHPAA (3 µM), inhibitors of the pro-inflammatory 
cytokines such as TNF-a, IL-1b and IL-6 in lipopolysaccha-
ride-stimulated peripheral blood mononuclear cells [70, 71]; 
and gallic acid (882 µM) inhibitor of Clostridium histolyti-
cum in in vitro faecal fermentation [65, 72].
The intra-group variation we observed could be due to 
the variation in gut microbiota, themselves influenced by 
genetics, lifestyle, diet and ageing. Older adults excreted 
a higher amount of hippuric acid in their urine. Hippuric 
acid is formed in the liver by conjugation of colonic benzoic 
acids with glycine; therefore, the high amount of HA could 
come from sources other than (poly)phenol-rich food metab-
olism, such as amino acids [68, 69]. Moreover, urinary hip-
puric acid correlated with hypertension and obesity [73, 74], 
which would be consistent with the characteristics of some 
in our older group. The high intra-group variability within 
the older group for the sum of the phenolic acids was mainly 
attributable for hippuric acid (30-fold difference between 
low and high excreters); however, the variability reduced to 
only threefold when hippuric acid was not included in the 
sum of phenolic acids.
Several potential mechanisms could explain the absence 
of some of the phenolic acids in the urine of participants as 
well as the low amount of phenolic acid excreted in the urine 
of the older group.
The first mechanism involves a decrease in colonic 
absorption. As the individual ages, colonic absorption is 
reduced and the mucosal surface area is diminished [75, 76]. 
During in vitro faecal fermentation of rutin, a high amount 
of PAA was detected in the faeces-only control at 0 h in the 
older group, suggesting that bacterial phenolic metabolism 
is not the sole source of increased PAA. The comparatively 
greater formation of PAA in the fermentation fluid of the 
older participants in the presence of rutin may also point 
toward a higher capacity of faecal material from older par-
ticipants to effectively metabolise rutin with the low urinary 
phenolic acid excretion due to poorer absorption of the phe-
nolic compounds in the colon. Variability in enterohepatic 
(re)circulation is not well studied and could be an additional 
contributing factor [77].
The second mechanism relates to the effect of age-
ing on the colonic microbiota composition and associated 
microbial and enzymatic activities. In the human colon, 
bacterial enzymes (β-glucosidases, β-glucuronidases, and 
α-rhamnosidase) hydrolyse rutin to release the querce-
tin aglycone [78]. Insufficient or lower levels of bacterial 
enzymes in the colon could be one reason for the absence 
and low urinary phenolic acid in the older group. Although 
these bacterial enzymes were not measured directly in this 
present study, we could not detect a difference between 
groups in the quantity of bifidobacteria, bacteroides, or Fla-
vonifractor plautii bacteria. The aim of the current protocol 
focusing on targeted bacteria was not to study the impact of 
dietary components, but instead to establish how pre-HPD 
levels of these bacteria could factor in the differences in 
phenolic acid excretion. Selected bacteria were measured 
in representative faecal samples and the values were not 
corrected for the total amount of daily faecal output, which 
could affect the accuracy of the measurement. Indeed, as 
the bacteria measurements were performed after the low-
polyphenol diet which was lower (but not devoid of) in 
fibre (younger: 9 g/day; older: 12 g/day), with a view to 
describe the levels of the targeted bacteria before exposure 
to the HPD. It is not clear how fibre intake impacts, short 
term (here, 3 days) on bacterial diversity and total numbers. 
Additionally, the selected bacteria measured in this study 
may not be representative of all bacteria responsible for 
(poly)phenol metabolism found in the colon such as Ente-
rococcus casseliflavus [53, 79] Butyrivibrio spp. [80], and 
Bacteroides distasonis [58], and may have been influenced 
by the nutrients in the low-polyphenolic diet (although the 
impact of such a short-term intervention on bacterial popula-
tions themselves is not clear). Based on this study’s finding, 
the differences in colonic fermentation between groups, as 
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modeled in vitro, are unlikely to be linked to the differences 
seen in the urinary phenolic acid excretion between groups. 
Woodmansey et al. [81] reported that a high faecal pH in the 
elderly (due to a low fibre intake) may lead to a reduction in 
SCFA production. In the present study, faecal pH was close 
to 8.0 in the older group after the LPD and above 7.0 after 
the HPD. However, even though the SCFA were higher in 
the older group after the HPD, there were no differences 
between groups when considering the change from the low 
to high-polyphenol diet. As mentioned above, the measure-
ment of the SCFA was performed in a representative faecal 
sample and correction for the total daily faecal output was 
not possible. A pH above 7.0 could be due to other com-
pounds such as ammonia, which have been reported in older 
adults [81], either due to lower fibre intake and/or increased 
activity of proteolytic bacterial species, such as Fusobacte-
ria, Propionibacteria, and Clostridia.
It is important when studying the bioavailability of bio-
active molecules to consider stratification of the population 
into responders and non-responders. Age and other factors 
such as gender, genetics, gut microbiota or physiological 
status involved in creating inter-individual variability are 
important to consider before developing such stratification 
models. Improvement in the knowledge of factors such as 
age, gender, genetic and gut microbiota composition, and 
their influence on the metabolism of plant food bioactive 
molecules, together with the development of methods to 
identify responsiveness profiles will enhance the develop-
ment of effective and innovative products for prevention of 
chronic disease [82]. The strength of this study includes the 
combination of in vivo and in vitro designs to assess the 
colonic bacterial metabolic ability of each group. However, 
the full profile of (poly)phenol metabolites was not measured 
in the urine and the phenolic acids were not measured in fae-
cal samples, which could have provided useful information 
regarding the absorption and accumulation of the phenolic 
compounds in the colon. Only selected bacterial species 
were measured in the faecal samples, and other gut bacte-
ria such as, Clostridium scindens, Eubacterium desmolans, 
Eubacterium ramulus [52, 60, 79, 83], Butyrivibrio sp [80], 
and Bacteroides distasonis [58] could potentially contribute 
to the colonic metabolism of dietary (poly)phenols.
The differential excretion of phenolic acids in older adults 
may be linked to differences in the gut microbiota profile or 
functionality, but may also be linked to other gastrointesti-
nal factors. Age was shown to impact on the phenolic acid 
profiles excreted in urine between groups qualitatively, as 
well as quantitatively (the younger group excreted higher 
phenolic acid in urine after both low- and high-polyphe-
nolic diets). These differences were not explained by the in 
vitro fermentations, as a similar range of phenolic acids was 
formed from the substrates in both groups, with minimal 
quantitative differences. Our study highlights the importance 
of study participant selection (and description) in experi-
mental design aiming to explore the colonic metabolism of 
plant bioactives. Age may be a factor influencing the con-
siderable variance in measurements seen in some studies. 
The restricted urinary phenolic acid profile observed in 
some participants in the older group may have relevance for 
colonic health, and should be investigated further.
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